Navigation Links
Abide Therapeutics Appoints Nancy Thornberry to Board of Directors
Date:7/29/2014

portant regulatory roles in human physiology and disease. Abide has created a proprietary platform, based on technology developed at The Scripps Research Institute by Professors Ben Cravatt and Dale Boger, that specifically targets serine hydrolases with selective small molecules. The ability to target and modulate serine hydrolases has potential to develop new medicines in many therapeutic areas. Abide is located in San Diego. To learn more, visit www.abidetx.com


'/>"/>
SOURCE Abide Therapeutics
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Abide Therapeutics Announces Collaboration With Merck to Develop Novel Therapies for Type 2 Diabetes and Metabolic Diseases
2. Abide Therapeutics Appoints Dr. Gary ONeill as Vice President of Biology
3. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
4. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
5. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
8. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
9. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
10. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
11. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , Sept. 30, 2014  Decision Resources Group finds that ... Australia , China , ... expand at a strong rate through 2023. Dental implant procedure volumes ... as patient awareness rises. Other key findings from Decision ... dental implant market: , Dental implant penetration: Penetration ...
(Date:9/30/2014)... 30, 2014 A study using a relatively ... new look at the composition of carotid artery disease ... and treat the disease, a leading cause of stroke. ... Lexington between September 2010 and May 2012, was featured ... of the American College of Cardiology (JACC) Cardiovascular Interventions. ...
(Date:9/30/2014)... Sept. 30, 2014 BioStructures, LLC has ... Association of Tissue Banks (AATB), it was announced ... Officer. Accreditation follows an intensive nine-month ... trained AATB inspector.  It establishes that the level ... facility meets or exceeds the standards set by ...
Breaking Medicine Technology:Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 2Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 3New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2Biostructures, LLC Earns AATB Accreditation 2
... SAN) and (NYSE: SNY)] announced today it has commenced a ... Genzyme Corporation (Nasdaq: GENZ ) for $69 per ... less any required withholding taxes.  The transaction is valued at ... sanofi-aventis, Board of Directors, is scheduled to expire at 11:59 ...
... Nephros, Inc. (OTC Bulletin Board: NEPH ... products for therapeutic applications, infection control, and water purification, ... bridge financing agreement with Lambda Investors LLC and has ... its stockholders.  Wexford Capital LP is the managing member ...
Cached Medicine Technology:Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash 2Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash 3Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash 4Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash 5Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash 6Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash 7Nephros Completes Bridge Financing and Announces Stockholder Rights Offering 2Nephros Completes Bridge Financing and Announces Stockholder Rights Offering 3Nephros Completes Bridge Financing and Announces Stockholder Rights Offering 4
(Date:9/30/2014)... Healthpointe is proud to announce that Dr. ... ankle reconstruction surgeries to assist patients with severe orthopedic ... in the diagnosis and treatment of sports medicine, and ... trained to perform advanced Foot and Ankle Reconstruction to ... also fluent in Spanish. , Reconstructive surgical procedures for ...
(Date:9/30/2014)... September 30, 2014 Catalent Pharma ... advanced delivery technologies and development solutions for drugs, ... full agenda for the 25th Annual CPhI Worldwide ... October 6th to 9th. , Catalent is showcasing ... expansions during the show, including its facilities in ...
(Date:9/30/2014)... CA (PRWEB) September 30, 2014 ... the grand opening of its newest practice, located at ... offers digital x-rays, general dentistry services , and ... surgery. In addition to providing affordable and convenient dental ... emergency dental appointments . Call Coast Dental at ...
(Date:9/30/2014)... CT (PRWEB) September 30, 2014 With accolades ... slot in Lash Masters II, Hilaree Brand of My Brand ... of the craft and, more importantly, the ability to teach. ... by solid credentials and a great reputation. , With a ... licensed as a Master of Aesthetics and as an Instructor. ...
(Date:9/30/2014)... (L-T4), long the standard of care for treating ... individuals do not regain optimal health on L-T4 ... to explain these differences. An expert task force ... replacement reviewed the latest studies on L-T4 therapy ... change to the current standard of care is ...
Breaking Medicine News(10 mins):Health News:Fellowship-Trained and Board-Certified Orthopedic Specialist Now Performing Advanced Foot & Ankle Reconstruction Surgeries 2Health News:Fellowship-Trained and Board-Certified Orthopedic Specialist Now Performing Advanced Foot & Ankle Reconstruction Surgeries 3Health News:Catalent Showcases Advanced Technologies and Supply Capabilities at CPhI Worldwide Conference and Exhibition 2Health News:Catalent Showcases Advanced Technologies and Supply Capabilities at CPhI Worldwide Conference and Exhibition 3Health News:Coast Dental Clovis Celebrates Grand Opening 2Health News:Coast Dental Clovis Celebrates Grand Opening 3Health News:My Brand Lashes and Lash Affair By J. Paris Merge to Offer Premium Lash and Brow Products and Certifications 2Health News:My Brand Lashes and Lash Affair By J. Paris Merge to Offer Premium Lash and Brow Products and Certifications 3Health News:New hypothyroidism treatment guidelines from American Thyroid Association 2
... Diseases Society of America (IDSA) released its first-ever guidelines for ... which will help physicians determine the most appropriate care for ... the most common cause of skin infections that send people ... people a year. Treatment of MRSA varies widely. ...
... HealthDay Reporter , TUESDAY, Jan. 4 (HealthDay News) ... seat belts, an increase that translates into many fewer injuries ... When the first state law requiring seat belts was ... wear them. But now, according to the U.S. Centers for ...
... , TUESDAY, Jan. 4 (HealthDay News) -- Levels ... suffer a type of heart attack called acute ST-segment elevation ... the most dangerous type of heart attack, STEMI occurs when ... large area of the heart. In the new ...
... Va. (Jan. 4, 2011) Virginia Commonwealth University School ... of an enzyme in the blood vessels of pregnant ... associated with the condition, including hypertension, swelling and protein ... a treatment for pregnant women with preeclampsia, which is ...
... , TUESDAY, Jan. 4 (HealthDay News) -- Rates of head ... including young women without any known risk factors. Now, a ... boosting the movement of precancerous cells in the mouth. ... handles estrogen after the lungs are exposed to smoke. This ...
... In the first combat-zone study of its kind, a ... with a positive outlook in the most traumatic situations were ... depression. The study, which surveyed Army troops fighting in ... who regularly deal with traumatic events such as death. Training ...
Cached Medicine News:Health News:IDSA announces first guidelines for treatment of MRSA infections 2Health News:IDSA announces first guidelines for treatment of MRSA infections 3Health News:IDSA announces first guidelines for treatment of MRSA infections 4Health News:Six Out of 7 Drivers Use Seat Belts: CDC 2Health News:Six Out of 7 Drivers Use Seat Belts: CDC 3Health News:Higher Education May Benefit Some Heart Attack Patients 2Health News:VCU findings may help explain some major clinical symptoms of preeclampsia 2Health News:Estrogen May Play Role in Rising Rates of Head, Neck Cancer 2Health News:MSU leads first study of resiliency on the battlefield 2
Stryker autoclavable pediatric laparoscopes provide equivalent brightness and resolution along with the unparalleled durability found in larger laparoscopes....
The flexible nature of the vinyl allows the user to reach deeper into the chamber and allows for a greater comfort when working inside the glove box over a long period of time compared to any rigid s...
Bactron IV is designed for high volume, yet requires far less bench space than expected for its capacity and performance features....
Designed for larger laboratories or research applications, the Concept 1000 boasts some very unique features....
Medicine Products: